Nuclear Medicine in Oncology

Molecular Imaging and Target Therapy

  • Gang Huang

Table of contents

  1. Front Matter
    Pages i-xi
  2. Liang Shi, Jianjun Liu
    Pages 1-10
  3. Xinzhong Hao, Xiaxia Meng, Zhifang Wu
    Pages 11-24
  4. Liu Liu, Maomei Ruan, Wenhui Xie
    Pages 25-45
  5. Xiaoli Lan, Altine Bouhari, Khamis Hassan Bakari, Alexandre Niyonkuru
    Pages 47-59
  6. Qian Xia, Gang Huang
    Pages 77-86
  7. Hubing Wu, Shaoli Song
    Pages 101-127
  8. Hongliang Fu, Suyun Chen, Hui Wang
    Pages 139-152
  9. Hubing Wu, DeWei Tang, XiaoPing Zhao, Gengbiao Yuan, Xinhui Su
    Pages 153-176
  10. Yafu Yin, Steven Rowe
    Pages 201-214
  11. Hui Wang, Xiao-Jun Zhang
    Pages 215-223
  12. Xiaoli Lan, Min Ye, Pengxin Qiao, Wenxia Wang
    Pages 225-233
  13. Rui Huang, Rong Tian, Zhaowei Meng
    Pages 235-255
  14. Qian Xu, Weishan Zhang, Chuantao Zuo
    Pages 257-266
  15. Xu Cheng
    Pages 267-295
  16. Rui Li, Qiang Jia, Zhaowei Meng, Shen Wang, Ruiguo Zhang, Wensen Jin et al.
    Pages 297-314
  17. Min Yang, Yuping Xu, Xinyu Wang, Yu Liu, Yanting Wang, Huimin Zhao et al.
    Pages 315-346

About this book


This book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively.

This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.



Editors and affiliations

  • Gang Huang
    • 1
  1. 1.Shanghai Key Laboratory of Molecular ImagingShanghai University of Medicine and Health SciencesShanghaiChina

Bibliographic information

  • DOI
  • Copyright Information Springer Nature Singapore Pte Ltd. and Shanghai Jiao Tong University Press 2019
  • Publisher Name Springer, Singapore
  • eBook Packages Medicine
  • Print ISBN 978-981-13-7457-9
  • Online ISBN 978-981-13-7458-6
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology